Updated recommendations on the use of hydroxychloroquine in dermatologic practice.
Hydroxychloroquine has unique immunomodulatory properties and an attractive adverse effect profile. Over the past 10 years, research has led to significant updates in clinical recommendations concerning the optimal use of hydroxychloroquine and monitoring of patients taking it. We discuss updated recommendations concerning hydroxychloroquine daily dosing, retinopathy screening, serologic monitoring, use in smokers, use in pregnant women, and adverse effect risk and monitoring. This review can hopefully serve as an aid to dermatologists and help ensure they continue using hydroxychloroquine safely and effectively.
Department of Dermatology, Cleveland Clinic, Cleveland, Ohio; Department of Pathology, Cleveland Clinic, Cleveland, Ohio. Electronic address: fernana6@ccf.org.
Anthony P
AP
Fernandez
D016903:Drug Monitoring; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012871:Skin Diseases / Q000188:drug therapy*
D006886:Hydroxychloroquine
adverse effects; hydroxychloroquine; lupus erythematosus; monitoring; recommendations; retinopathy screening; whole blood levels